Literature DB >> 30963066

Quadriceps tendinopathy: a review-part 1: epidemiology and diagnosis.

Dominic King1, George Yakubek1, Morad Chughtai1, Anton Khlopas1, Paul Saluan1, Michael A Mont1,2, Jason Genin1.   

Abstract

Overuse injuries of the extensor mechanism of the knee are common in both athletes and non-athletes and usually occur during activities associated with repetitive loading, stress, and knee extension. Historically, they have been labeled as Jumper's knee due to the high prevalence seen in the athletic community. In many published reports, the name "patellar tendinopathy" is used to describe this disorder of the quadriceps tendon at the patellar insertion, and the names are often used interchangeably. Numerous reports have been published describing extensor mechanism injuries in athletes, but there is a paucity of studies that focus on quadriceps tendinopathy. In addition, there is no universally accepted classification system for tendon pathology. Therefore, we performed a comprehensive literature review of these studies. This review consists of 2 parts. In the first part we review: (I) epidemiology and (II) diagnosis of quadriceps tendinopathy in the athlete as well as the general population. In the second part we discuss: (I) classification; (II) prognosis; and (III) treatment results.

Entities:  

Keywords:  Quadriceps; diagnosis; epidemiology; tendinopathy

Year:  2019        PMID: 30963066      PMCID: PMC6409230          DOI: 10.21037/atm.2019.01.58

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  2 in total

1.  IN-SEASON REHABILITATION PROGRAM USING BLOOD FLOW RESTRICTION THERAPY FOR TWO DECATHLETES WITH PATELLAR TENDINOPATHY: A CASE REPORT.

Authors:  Tyler Cuddeford; Jason Brumitt
Journal:  Int J Sports Phys Ther       Date:  2020-12

2.  Is There a Relationship Between Quadriceps Tendinopathy and Suprapatellar Plica? An Observational Case Series.

Authors:  Håkan Alfredson; Lorenzo Masci; Christoph Spang
Journal:  Int Med Case Rep J       Date:  2022-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.